Publication | Closed Access

Laquinimod (ABR-215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1/Th2 balance and induces the Th3 cytokine TGF-β in Lewis rats

InflammationAutoimmune DiseaseImmune Cell DevelopmentMedicineImmune RegulationImmunologyPathologyTh1/th2 BalanceAutoimmunityHumoral ImmunityImmunologic DiseaseImmune FunctionLewis RatsImmune SystemNeuroimmunologyImmune DysregulationTh3 Cytokine Tgf-β